Advanced Epithelioid Sarcoma
1 clinical trials · Condition
◉ Watch Advanced Epithelioid Sarcoma
| Record | Firm | Date |
|---|---|---|
| Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma (NCT04204941) | Epizyme, Inc. | 2019-12-19 |
Track Advanced Epithelioid Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.